Pages that link to "Q71384561"

The following pages link to Peroxisomal fatty acid oxidation is selectively inhibited by phenothiazines in isolated hepatocytes (Q71384561):

Displaying 11 items.

• On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders (Q34738513) (← links)
• Involvement of carnitine acyltransferases in peroxisomal fatty acid metabolism by the yeast Pichia guilliermondii (Q39800859) (← links)
• Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes (Q41142588) (← links)
• Comparison of the activities of some peroxisomal and extraperoxisomal lipid-metabolizing enzymes in liver and extrahepatic tissues of the rat. (Q41853874) (← links)
• Catalase-dependent ethanol oxidation in perfused rat liver. Requirement for fatty-acid-stimulated H2O2 production by peroxisomes (Q42519674) (← links)
• Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids (Q42855382) (← links)
• Experimental inhibition of peroxisomal beta-oxidation in rats: influence on brain myelination. (Q64948207) (← links)
• Short and long term influence of phenothiazines on liver peroxisomal fatty acid oxidation in rodents (Q69397624) (← links)
• Suppression of clofibrate-induced peroxisome proliferation in rat liver by nicardipine, a calcium antagonist (Q69919169) (← links)
• Altered adrenocortical response under the influence of experimentally increased serum very long chain fatty acids in rats (Q70476554) (← links)
• Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients (Q71719467) (← links)